triumphant news!

Rocky Biology won two honors in succession!

《Xingyao List-2020 China's Top 50 Most Innovative Biopharmaceutical Enterprises》

《"2020 China Overseas Students Pioneer Park is the most promising entrepreneurial enterprise"》

Xingyao List of China's top 50 most innovative biomedical enterprises in 2020

    On November 2-3, the 2020 BPID Bio-pharmaceutical Industry Development Conference and the Star Show Awards Ceremony hosted by Medical Media was held in Suzhou. With its excellent scientific research strength and advanced innovation concept, "Luoqi Biologics" stands out from hundreds of biopharmaceutical enterprises and is selected as the "Top 50 Most Innovative Biopharmaceutical Enterprises in China on the Star List - 2020". The evaluation is based on the potential investment value, R&D innovation ability, clinical progress of new drugs, industry reputation, etc., and has the significance of industry wind vane.

2020 China Overseas Students Pioneer Park is the most growing entrepreneurial enterprise

    On November 27, the "2020 Most Growing Entrepreneurship Enterprises in China's Overseas Chinese Entrepreneurship Park", jointly guided by relevant national ministries and commissions and sponsored by the China Technology Entrepreneurship Association Overseas Chinese Entrepreneurship Park Alliance, was officially held. After the preliminary review, re-examination and general review of the review committee, "Luoqi Biological" won the title of "the most growing entrepreneurial enterprise" with its excellent technological innovation and outstanding development potential.

    The selection of Rocky Biology is a high affirmation of the R&D innovation and comprehensive competitiveness of Rocky Biology by industry experts and relevant institutions. In the future, Loqi Biology will adhere to the concept of "providing patients with newer and safer innovative drugs", continue to increase investment in high-tech research and development, continuously improve its independent innovation ability, and strive to realize the new drug dream of "Camel Antibody Starts a Healthy Future" as soon as possible.

About novamab

     Luoqi Biology is a high-tech enterprise dedicated to the research and development of innovative nano antibody drugs. The company was established in Shanghai International Medical Park, with a R&D and production base of more than 1600 square meters and a unique camel breeding base. Luoqi Biological has independently created five core technology platforms based on nano-antibody: nano-antibody rapid screening platform, Pichia pastoris CMC process development platform, inhaled macromolecular drug research and development platform, nano-antibody long-acting platform and nano-antibody dual-antibody platform, all of which have very unique industry advantages. At present, the company is mainly developing products to cover popular targets such as respiration, ophthalmology and cancer, and has developed product research and development strategies for innovative application scenarios to improve drug utilization and patient compliance.